Real estate equities were mixed this week, as some much-needed relief on the interest rate front was offset by pressure on ...

Silicon Motion is a profitable, well-managed niche leader trading at a discount, with strong margins and financial discipline ...

S&P Global combines market dominance, AI innovation, and steady cash flows to thrive in volatile times. Find out why SPGI ...

During Q1 of 2025, the portfolio outperformed the MSCI EAFE benchmark driven primarily by security-specific effects, and sector allocation was also additive. Read more here.

S&P Global’s strong model, improved macro outlook, and upcoming Mobility spin-off support growth and fair valuation at 26.5x ...

Blue Bird delivered record EV sales in Q2 FY25, helping drive 3.8% YoY topline growth despite tough prior-year comps. Strong ...

Gilead Sciences shows strong Q1 execution, pipeline momentum, and margin upside, led by HIV and PrEP launches. See why GILD ...

SPLG offers affordable access to the S&P 500 with a lower price and expense ratio, ideal for small investors. Read more on ...

AbbVie is undervalued with strong EPS growth, rising immunology revenue, and a 3.43% yield. Check out ABBV's robust pipeline ...

Discover why XYZ remains a top investment pick with strong financials, growth potential, and discounted valuation.

Amphenol boasts strong financials, robust free cash flow, and exposure to high-growth sectors support long-term investment.

TSM posted 39.6% YoY growth in May, gained share over Samsung, and leads in 2nm yields, all while trading under 20x FY26 EPS.